The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.

Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease ...

Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90%Underscores Royalty Pharma’s commitment to enhanced corporate ...

New emerging life sciences hubs are gaining ground amid the market shift.

Shares of Abbott Laboratories slid 8.52% to $120.51 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.54% to 6,297.36 and the ...

The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...

A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles being faced by the company.

CNBC’s Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its quarterly report.

J&J's diversified business, robust pipeline, and strong free cash flow provide stability, despite legal challenges. Read more ...

The global clinical nutrition market is set to witness a growth rate of 7% in the next 5 years. Increasing aging population ...

Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...

Global Growth Insights Healthcare Market expansion continues, climbing from USD 13695.28 Billion in 2025 to USD 22347.74 Billion by 2033, f ...